This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Apr 20;29(12):1503-4.

doi: 10.1200/JCO.2010.34.2758. Epub 2011 Mar 14.

The war on cancer: progress at what price?

PMID: 21402613
DOI: 10.1200/JCO.2010.34.2758

Editorial

The war on cancer: progress at what price?

Andre Konski. J Clin Oncol. 2011.

. 2011 Apr 20;29(12):1503-4.

doi: 10.1200/JCO.2010.34.2758. Epub 2011 Mar 14.

Author

PMID: 21402613
DOI: 10.1200/JCO.2010.34.2758

No abstract available

PubMed Disclaimer

Comment on

Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y, Hoffman KE, Hu JC. Nguyen PL, et al. J Clin Oncol. 2011 Apr 20;29(12):1517-24. doi: 10.1200/JCO.2010.31.1217. Epub 2011 Mar 14. J Clin Oncol. 2011. PMID: 21402604 Free PMC article.

Similar articles

Cost of cancer care: issues and implications.
Meropol NJ, Schulman KA. Meropol NJ, et al. J Clin Oncol. 2007 Jan 10;25(2):180-6. doi: 10.1200/JCO.2006.09.6081. J Clin Oncol. 2007. PMID: 17210937 Review.
How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD. Ramsey SD. J Clin Oncol. 2007 Jan 10;25(2):175-9. doi: 10.1200/JCO.2006.08.9805. J Clin Oncol. 2007. PMID: 17210936 No abstract available.
Is high and growing spending on cancer treatment and prevention harmful to the United States economy?
Pauly MV. Pauly MV. J Clin Oncol. 2007 Jan 10;25(2):171-4. doi: 10.1200/JCO.2006.08.7536. J Clin Oncol. 2007. PMID: 17210935 No abstract available.
Cost of cancer care: the patient perspective.
Kim P. Kim P. J Clin Oncol. 2007 Jan 10;25(2):228-32. doi: 10.1200/JCO.2006.07.9111. J Clin Oncol. 2007. PMID: 17210945 Review.
[Oncology caught between economics and efficiency].
Keil TU. Keil TU. Med Klin (Munich). 2000 Jun;95 Suppl 1:1. Med Klin (Munich). 2000. PMID: 10941245 German. No abstract available.

See all similar articles

Cited by

Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.
Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Tina Shih YC. Smith GL, et al. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):450-461. doi: 10.1016/j.ijrobp.2016.10.042. Epub 2016 Nov 8. Int J Radiat Oncol Biol Phys. 2017. PMID: 28011046 Free PMC article.
"Just caring": can we afford the ethical and economic costs of circumventing cancer drug resistance?
Fleck LM. Fleck LM. J Pers Med. 2013 Jul 16;3(3):124-43. doi: 10.3390/jpm3030124. J Pers Med. 2013. PMID: 25562649 Free PMC article.
Novel antibody-based proteins for cancer immunotherapy.
Fuenmayor J, Montaño RF. Fuenmayor J, et al. Cancers (Basel). 2011 Aug 19;3(3):3370-93. doi: 10.3390/cancers3033370. Cancers (Basel). 2011. PMID: 24212958 Free PMC article.
First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital.
Ogawa Y, Ikeda K, Izumi T, Okuma S, Ichiki M, Ikeya T, Morimoto J, Nishiguchi Y, Ikehara T. Ogawa Y, et al. Int J Clin Oncol. 2013 Jun;18(3):447-53. doi: 10.1007/s10147-012-0401-0. Epub 2012 Mar 14. Int J Clin Oncol. 2013. PMID: 22415743

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.